Akebia Therapeutics Inc. buy Piper Sandler
Start price
06.02.26
/
50%
€1.29
Target price
06.02.27
€3.39
Performance (%)
-5.21%
Price
20.03.26
€1.21
Summary
This prediction is currently active. With a performance of -5.21%, the BUY prediction for Akebia Therapeutics Inc. by Piper_Sandler is down slightly. This prediction currently runs until 06.02.27. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akebia Therapeutics Inc. | -4.355% | -4.355% |
| iShares Core DAX® | -4.932% | -11.977% |
| iShares Nasdaq 100 | -2.634% | -2.218% |
| iShares Nikkei 225® | -4.733% | -10.900% |
| iShares S&P 500 | -2.544% | -3.540% |
Comments by Piper_Sandler for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics (NASDAQ:AKBA) had its price target lowered by analysts at Piper Sandler from $6.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by Piper_Sandler for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.97
14.03.25
14.03.25
€5.53
14.03.26
14.03.26
-34.31%
15.03.26
15.03.26
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
31.05.23
31.05.23
-
31.05.24
31.05.24
13.76%
01.06.24
01.06.24